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Abstract
Background: Liver plays a profound role in the acute phase response (APR) observed in the early
phase of acute bovine mastitis caused by Escherichia coli (E. coli). To gain an insight into the genes
and pathways involved in hepatic APR of dairy cows we performed a global gene expression analysis
of liver tissue sampled at different time points before and after intra-mammary (IM) exposure to E.
coli lipopolysaccharide (LPS) treatment.
Results:  Approximately 20% target transcripts were differentially expressed and eight co-
expression clusters were identified. Each cluster had a unique time-dependent expression profile
and consisted of genes involved in different biological processes. Our findings suggest that APR in
the liver is triggered by the activation of signaling pathways that are involved with common and
hepatic-specific transcription factors and pro-inflammatory cytokines. These mediators in turn
stimulated or repressed the expression of genes encoding acute phase proteins (APP), collectins,
complement components, chemokines, cell adhesion molecules and key metabolic enzymes during
the APR. Hormones, anti-inflammatory and other hypothalamus-pituitary-adrenal axis (HPAA)
linked mediators also seemed to participate in APR.
Conclusion: Performing global gene expression analysis on liver tissue from IM LPS treated cows
verified that the liver plays a major role in the APR of E. coli mastitis, and that the bovine hepatic
APR follows the same pattern as other mammals when they are challenged with LPS. Our work
presents the first insight into the dynamic changes in gene expression in the liver that influences
the induction, kinetics and clinical outcome of the APR in dairy cows.
Background
Mastitis caused by Escherichia coli (E. coli) is a common
disease in lactating dairy cows. During infection, lipopol-
ysaccharide (LPS) released from the cell wall of E. coli rap-
idly induces a sophisticated inflammatory response.
Locally it is characterized by recruiting leukocytes espe-
cially neutrophils to the injured mammary tissue, as well
as activation of macrophages in the mammary gland to
produce pro-inflammatory cytokines [1]. These pro-
inflammatory cytokines include tumor necrosis factor-
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alpha (TNF-α), interleukin-1 (IL-1) and interleukin-6 (IL-
6), which have profound roles in the inflammatory
response. Systemic consequences are observed as the
acute phase response (APR) phenomena such as fever,
leukocytosis and altered plasma concentration of acute
phase proteins (APP). LPS is a highly potent activator of
the pro-inflammatory response during E. coli infection
and is often used to simulate the gram negative mastitis. It
provokes secretion of above pro-inflammatory cytokines
which in turn activate or suppress expression of acute
phase genes in hepatocytes, vascular endothelium and
other target cells [2,3]. Although some extra-hepatic pro-
duction occurs [4,5], the liver is thought to be the major
contributor to the APP in the blood. APR is also com-
monly accompanied by a widespread change of metabo-
lism [6].
The contribution of the liver to the circulating levels of
cytokines and APP in vivo in cattle is not fully understood.
In cattle, in vitro studies using Kupffer cells (liver macro-
phages) have shown an important contribution of liver to
the cytokine production [7]. In vitro, recombinant bovine
cytokines can stimulate the secretion of haptoglobin (HP)
from bovine hepatocytes [8]. Furthermore, synthesis of
serum amyloid A (SAA) was shown to be mainly regulated
by TNF-α, IL-1, IL-6 and glucocorticoid via a network of
transcription factors and antagonists [9]. Our previous
study shows that liver has a great capacity to produce both
pro- and anti-inflammatory cytokines and APP when
dairy cows are infused LPS intra-mammary (IM) [10]. All
these studies suggest a strong connection between
cytokines activity and APP production in cattle during
inflammation.
The biological functions of APP such as HP and SAA in the
APR are only partly known. Although the APP is highly
conserved during evolution [11], their presence and
importance differ among animal species. The significantly
elevated APP expression in liver and increased concentra-
tion in blood and milk during udder infection indicate a
crucial role of these proteins in the host's anti-pathogen
response to mastitis [10,12,13]. Other genes involved in
the energy metabolism, integrity and function of hepato-
cytes are also expected to be regulated in the liver during
the APR, and may influence the induction, kinetics and
clinical outcome of the APR to LPS induced inflammation
in dairy cows [3].
To gain a better insight into the genes and pathways
involved in hepatic APR in dairy cows, we performed a
global gene expression analysis of liver tissue sampled at
different time points relative to intra-mammary exposure
to LPS treatment.
Results
Of the 24128 target transcripts measured by the microar-
ray approximately 20% were differentially expressed (DE)
at one or more time points relative to LPS treatment. A
heatmap of the 4610 DE transcripts is shown in Figure 1.
These transcripts were grouped into eight clusters and the
average expression profile of each cluster is shown in Fig-
ure 2. Most transcripts exhibit a single upward or down-
ward wave with the expression of 2408 transcripts
increased (cluster 1, 2, 3 and 5) and 1945 transcripts
decreased (cluster 4, 6 and 8), respectively, over the time
course measured. However some transcripts showed a
bimodal expression pattern between 6 and 12 hours after
LPS treatment (cluster 7, n = 257). Transcripts from clus-
ters 1 and 8 responded rapidly within 3 hours after LPS
treatment. The majority of transcripts exhibited a maximal
deviation from baseline at 6–12 hours post LPS infusion
(cluster 2, 3, 4, 5, and 6). Most transcripts returned to
baseline at 48 hours after LPS treatment.
Overrepresentation of gene sets defined by the Biological
Process (BP) of Gene Ontology (GO) was tested within
each cluster. The BPs shown in Figure 3 was overrepre-
sented in at least one cluster (p < 0.01). Cluster 1 contains
82 transcripts and the average expression was character-
ized by a rapid increase within 3 hours after LPS treatment
that is followed by a quick return to the baseline (cluster
1 in Figure 2). A significant proportion of the genes in this
cluster are involved in immune and inflammatory
responses (GO:0006954; GO:0006955), chemotaxis
(GO:0006935), cyclooxygenase pathway (GO:0019371)
and macrophage differentiation (GO:0030225). It
includes genes encoding IL-1 alpha and beta, chemokine
(C-X-X motif) ligand 1 (CXCL1), chemokine (C-C motif)
ligand 2 (CCL2), ligand 8 (CCL8), prostaglandin-
endoperoxide synthase 2 (PTGS2, also known as cycloox-
ygenase-2, COX-2), colony stimulating factor 1 (macro-
phage, CSF1) and CCAAT/enhancer binding protein delta
(CEBPD). Cluster 2 contains 1146 transcripts whose max-
imum expression occurred at 9–12 hours (cluster 2 in Fig-
ure 2). The overrepresented BP are phosphorylation
(GO:0016310) and negative regulation of receptor medi-
ated endocytosis (GO:0048261). This cluster includes toll
interacting protein (TOLLIP), CD97, epidermal growth-
factor receptor (EGFR), signal transducer and activator of
transcription 3 (STAT3), AMP-activated protein kinase
beta 1 non-catalytic subunit (PRKAB1) as well as HP.
Cluster 3 contains 1010 transcripts whose expression
increased 3 hours after LPS infusion and have a maximum
expression at 6 to 9 hours (cluster 3 in Figure 2). Involved
BP are cytokine and chemokine mediated signaling path-
way (GO:0019221), positive regulation of inflammatory
response (GO:0050729), negative regulation of signal
transduction (GO:0009968), heterophilic cell adhesion
(GO:0007157) and apoptosis (GO:0006915). The DEBMC Genomics 2008, 9:443 http://www.biomedcentral.com/1471-2164/9/443
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transcripts include the genes encoding toll-like receptor 2
(TLR2), tumor necrosis factor receptor superfamily, mem-
ber 1A (TNFRSF1A), member 5 TNFRSF5, interleukin 1
receptor antagonist (IL1RN), myeloid differentiation pri-
mary response gene 88 (MYD88), NF-kappaB (NFKB)
transcription factor p65 subunit (human homolog
NFKB3), NF-kappaB inhibitor alpha (NFKBIA), activating
protein-1 AP1 (also known as JUN), suppressor of
Heatmap of differentially expressed transcript sets Figure 1
Heatmap of differentially expressed transcript sets. 4610 transcripts were differentially expressed (adjusted P < 0.01). 
Normalized intensity values of transcripts (rows) are ordered using Centered Pearson correlation and hierarchical clustering. 
The dendrogram show the similarity (distance) of expression profile of transcripts and is divided into 8 sub-trees as indicated 
in the color bar. Arrays (columns) are grouped according to the sampling time which varies from -22 to 48 hours subject to 
LPS infusion. Red and green colors reflect the high and low intensities respectively.
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cytokine signaling 3 (SOCS3) and APP SAA3 and alpha-1
acid glycoprotein (AGP) as well as intercellular adhesion
molecule 1 (CD54 or ICAM-1), peroxisome proliferator
activated receptor gamma coactivator 1 alpha
(PPARGC1A/PGC-1/PGC-1α) and scavenger receptor
class B, member 1 (SCARB1). Cluster4  contains 1610
transcripts whose expression was down regulated with a
minimum at 9 to 12 hours after LPS administration (clus-
ter 4 in Figure 2). The enriched biological processes are
related to the amino acid metabolic process
Expression profile of individual cluster Figure 2
Expression profile of individual cluster. Each expression profile corresponds to a sub-tree (color match) in Figure 1. The 
cluster size (number of transcripts) is shown inside parenthesis. Y-axis represents the average value of log2-transformed 
expression intensity and x-axis represents the time series chronologically (-22, 3, 6, 9, 12, 48) subject to LPS treatment. A 
description of the genes included in each clusters are given in the result section.
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Gene Ontology enrichment in individual cluster Figure 3
Gene Ontology enrichment in individual cluster. In total 89 GO biological processes (rows) are overrepresented (p < 
0.01) within the 8 clusters. Each cluster (columns) corresponds to a sub-tree mapped in Figure 1, with the expression profile 
and size illustrated in Figure 2. Referring to the scale of color key, each lane stands for the P value of overrepresented GO-BP 
within each cluster. The yellow background stands for the non-significance (p > 0.01).
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(GO:0006520), glucose metabolic process
(GO:0006006), lipid metabolic process (GO:0006629),
fatty acid metabolic process (GO:0006631), steroid bio-
synthetic process (GO:0006694) and proteolysis
(GO:0006508). Among the genes in this cluster are phos-
phoenolpyruvate carboxykinase 1 (PCK1), glucose-6-
phosphatase catalytic subunit (G6PC), corticosteroid-
binding globulin (CBG) precursor and prolactin receptor
(PRLR), as well as complement component 4-binding
protein, beta (C4BPB) and mannose-binding lectin
(MBL). Cluster 5 contains 170 transcripts which were up
regulated temporarily from 3 to 6 hours (cluster 5 in Fig-
ure 2) and return to the baseline within 12 hours. The
involved biological processes are response to DNA dam-
age stimulus (GO:0006974), activation of pro-apoptotic
gene products (GO:0008633) and DNA metabolism
(GO:0006259). The DE transcripts include the gene
encoding chemokine (C-C motif) ligand (CCL20). Clus-
ter 6 contains 310 transcripts which were down regulated
temporarily between 3 to 6 hours and returned to the
baseline within 12 hours (cluster 6 in Figure 2). Cytoskel-
etal anchoring (GO:0007016) was found overrepresented
and this cluster includes genes encoding 6-phosphof-
ructo-2-kinase (PFKFB2), suppressor of cytokine signaling
2 (SOCS2) and hepatocyte nuclear factor 3 (HNF-3)
alpha. Cluster 7 contains 257 transcripts. The expression
profile of these genes is bimodal and is characterized by a
decrease from 3 to 6 hours followed by a rapid increase
from 6 to 12 hours and then returning to baseline at 48
hours (cluster 7 in Figure 2). Genes involved in cellular
homeostasis (GO:0019725) and mitochondrial transport
along microtubule (GO:0047497) are overrepresented.
Cluster 8 contained 25 transcripts which rapidly declined
within 3 hours (cluster 8 in Figure 2). Regulation of tran-
scription by RNA polymerase II promoter (GO:0006357)
and regulation of transcription (GO:0045449) are the
overrepresented biological processes and it includes
CCAAT/enhancer binding protein alpha (CEBPA).
The performance and sensitivity of the microarray analysis
was validated against quantitative PCR (Q-PCR) per-
formed on the same liver tissue samples [10]. Seven
inflammatory markers including the pro- and anti-inflam-
matory cytokine TNF-α, IL-1β, IL-6 and IL-10 and the APP
HP, SAA3 and AGP were tested. All markers, except AGP
were found to be significantly up regulated when meas-
ured using Q-PCR [10]. The expression profiles from the
microarray showed the same trends as Q-PCR for most
investigated markers except AGP and IL-6 (Figure 4).
Among the cytokines IL-1β and IL-10 were significantly
up regulated on the microarray, but not TNF-α and IL-6.
To ensure a low false discovery rate we have chosen to
adjust for multiple testing using the stringent Bonferroni
method. This means that some genes with significantly
low raw p-values which is the case for TNF-α and IL-6 will
be deemed non differentially expressed after adjusting for
multiple testing although the expression profile of TNF-α
is very similar to that observed by Q-PCR. Also the two
technologies have different sensitivity, because Q-PCR has
a 40-cycle amplification while the Affymetrix array is
loaded with cRNA that is amplified normally no more
than 2 cycles. This means that inflammatory cytokine
which normally are present in picogram or nanogram in
blood and liver are easier detected using Q-PCR. In con-
trast, the APP that often are present in microgram or mil-
ligram in the blood of diseased individuals, were all found
to be significantly up regulated on the microarray.
Discussion
This study presents the first global gene expression profil-
ing of the hepatic APR in dairy cows following intra-mam-
mary exposure to LPS. Clinical findings (e.g. fever, high
somatic cell count (SCC) in the milk, temporary leukope-
nia, leukocytosis) verified the induction of mastitis
inflammation by LPS. The bovine array data strongly sup-
port that the hepatic APR is triggered by the activation of
the signaling pathways that are involved with common
and hepatic-specific transcription factors and pro-inflam-
matory cytokines. These mediators in turn stimulates or
represses the expression of genes encoding APP, col-
lectins, complement components, chemokines, cell adhe-
sion molecules and key metabolic enzymes during APR.
Hormones, anti-inflammatory and hypothalamus-pitui-
tary-adrenal axis (HPAA) linked mediators also seem to
participate in the modification of APR. The alteration of
these acute phase genes is thought to be responsible for
the observed systemic APR phenomena.
The overall gene expression pattern of the hepatic APR in
dairy cows depicts what has been found in other animal
LPS models such as mice, canine and sheep using different
LPS application routes. In the liver of mice given intraperi-
toneal (i.p.) LPS there was an up regulation of genes
involved in defense and immunity, and intracellular sign-
aling while genes involved in metabolism of fatty acid,
bile acid and cholesterol were down regulated [3]. Similar
findings in the liver of intravenous (i.v.) LPS-challenged
sheep [14,15] and canine [16] suggests that the changes in
the gene expression we have in the bovine liver during
APR is a common response in mammalian species. In the
following sections, changes in individual gene expres-
sions in LPS challenged dairy cows will be discussed in
relation to the existing and general knowledge of the
hepatic APR.
Initiation of APR in liver
LPS IM infusion induces systemic APR, which in the liver
is associated with the pro-inflammatory cytokines pro-
duced by the activated macrophages. CD14 and TLR4 are
the cell membrane proteins which bind LPS and may trig-BMC Genomics 2008, 9:443 http://www.biomedcentral.com/1471-2164/9/443
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Comparing the expression profile of 7 selected genes measured using Q-PCR and microarray Figure 4
Comparing the expression profile of 7 selected genes measured using Q-PCR and microarray. The mRNA 
expression of HP, SAA3, AGP, IL-1β, IL-6 and IL-10 and TNF-α were detected using Q-PCR (blue unfilled bar) and microarray 
(yellow solid bar) technologies. The height of the bar indicates the average signal units. Left (right) Y-axis is the scale of micro-
array (Q-PCR) data. Asterisk (*), caret (^) and plus (+) symbol in the bottom indicate significant (p < 0.05) DE when comparing 
a time point after LPS treatment (3, 6, 9, 12 or 48 hours) to -22 hours before the infusion. Asterisk indicates significance in 
both microarray and Q-PCR; caret and plus indicate significance only in microarray or Q-PCR respectively. The signal units for 
microarray are the intensities before the log base 2 scale transform and the asterisk and caret signs for microarray are the p 
values after Bonferroni correction.
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ger the signaling pathways of macrophages activation
[17,18]. TLR2 also has a recognizable role in the inflam-
matory activation of liver shown in mice by i.p. LPS treat-
ment [19]. TLR2-MYD88 elicits the signaling cascades that
activate AP1 and NFKB [20]. The latter promotes the tran-
scription of IL-6 and TNF-α [21,22]. We observed that the
expressions of TLR2,  MYD88,  AP1  and p65 subunit
(NFKB3) of NFKB complex, its inhibitor (NFKBIA), both
IL-1α and IL-1β, and IL-1 receptor antagonist IL1RN were
all up regulated. Although the increased expression of IL-
6 and TNF-α is less dramatic when measured using the
microarray, it is significant using Q-PCR [10]. Increased
expression was also observed in the cytokine receptors like
TNFRSF1A and TNFRSF5 (CD40), and the component of
receptor pathway such as TOLLIP, which is an essential
element of the IL-1 receptor signaling pathway [23].
Hormones are another family of key mediators involved
in APR. We found a decreased expression of prolactin
receptor (PRLR), similar to that shown in hepatic tissue
after i.p. LPS injection [24]. PRL induced STAT3  [25]
which however was up regulated in our study. One expla-
nation is that in the liver STAT3  is also inducible by
growth hormone (GH), IL-6 family cytokines and epider-
mal growth factor (EGF) [26,27], and we did observe
increased expression of the EGF receptor. Activated STAT3
can enhance the transcription of C/EBPs and AP1, which
both are important transcription factors controlling the
production of APP and other inflammatory genes such as
SCARB1 that participates in the clearance of LPS in the
liver [28-30]. We observed an elevated expression of C/
EBPδ, AP1 and SCARB1. In addition, SOCS2 and SOCS3,
the attenuator of STAT3  mediated signal transduction,
were also altered.
It seems APR predominantly relies on the activation of sig-
naling pathways involved with transcription factors and
pro-inflammatory cytokines. And it may subject to the
modification by the hormones via the corresponding
receptors. The coordination of pro- and anti-inflamma-
tory mediators such as inhibitors or antagonists also par-
ticipated and may provide the host with a state of "high
alert" in which the immune response can be efficiently
initiated if the infection progresses, and restrained if the
infection is resolved or becomes excessive or prolonged.
HPAA and APR in liver
Fever was observed in the cows after LPS challenge and as
a physiological stress, it can lead to the change of serum
cortisol levels. Prostaglandin (PG) E2 has a profound role
in thermoregulation during infection [31]. In LPS-
induced fever, first febrile phase (~0.5 hour post LPS) is
triggered by the activation of PGE2 synthesis mainly in
macrophages in liver and lung [32]. PGE2 is synthesized
via the cyclooxygenase pathway in which COX-2 is the key
enzyme. We found increased expression of COX-2 in the
liver within 3 hours after LPS IM infusion. In fact, APR
represents a cross-talk between the peripheral inflamma-
tion and central nervous system [33]. During infection
HPAA is activated by pro-inflammatory cytokines and
influences the inflammation by releasing glucocorticoids
such as cortisol [15,34]. The majority of cortisol in serum
is bound to CBG and is biological inactive [35]. We
observed a decreased expression of CBG in the bovine
liver and studies of human HepG2 cell in vitro showed
that pro-inflammatory cytokines IL-1 and IL-6 can
decrease CBG synthesis [36]. The expected outcome is
increased levels of unbound (active) cortisol in serum in
response to the local inflammation in the mammary
gland. It suggests that HPAA linked mediators (cortisol
and PGE2) may respond to the expression change of acute
phase genes in liver.
Expression of APP
APP is one of the most important products of the liver
during the infection. We observed that the expression of
major positive APP such as SAA3, HP and AGP were all up
regulated. No significant change was observed in C-reac-
tive protein, shown to be less responsive in cattle as com-
pared to human, pigs and dogs during the acute infection
[4]. SAA, HP and AGP are class I APP which dependent on
IL-1-NFKB signaling pathway and contain C/EBP binding
sites in their promoter regions [37]. In our study C/EBPδ
was elevated while C/EBPα  was decreased less than 3
hours after LPS treatment confirming the inverse relation-
ship between these transcription factors during APR [38].
STAT3, a class II acute phase gene (induced by IL-6), was
also up regulated is known to stimulate the transcription
of C/EBPs as described previously and thereby affecting
expression of the APP indirectly. The increased expression
of common (NFKB,  STAT3) and hepatic-selective (C/
EBPδ) transcription factors suggests that the expression of
APP is controlled by a network of transcription factors
involving both classes of the acute phase genes.
It is also notable that some APP from the complement
pathway or collectin family, for example MBL, was down
regulated. Studies in humans have shown that IL-1 can
suppress the MBL  expression [39]. Another example is
C4BPB, a crucial regulator in both the classical and lectin
pathways. Expression levels of up stream regulators of
C4BPB  such as HNF-3  and  PFKFB2  [40,41] were sup-
pressed, which may explain the decreased expression of
C4BPB we observed in the bovine liver during the APR.
Complement components (CC) and collectins are consid-
ered as the first line of defense against pathogen invasion.
However in our study, LPS was infused into the mammary
gland and decreased expression of collectins and CC may
be due to the absence of direct binding to the foreign sur-
face antigen.BMC Genomics 2008, 9:443 http://www.biomedcentral.com/1471-2164/9/443
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Leukocytes recruitment and activation
Leukocytosis was observed in the LPS treated cows and
correspondingly we also observed an increased expression
of genes, which play a key role in leukocytes migration
and activation in the liver. Among those genes are 1)
chemokines: macrophage inflammatory protein (MIP-
3α/CCL20), monocyte chemotactic proteins (MCP-1/
CCL2, MCP-2/CCL8) and neutrophil-activating protein
NAP-3/CXCL1; 2) cell-adhesion molecules (CAM): ICAM-
1; and 3) other cell surface molecules and colony stimu-
lating factors: CD97 and CSF-1. CD97 plays an essential
role in migration of leukocytes particularly neutrophils
[42], and it is a marker of early lymphocyte activation
[43,44]. CSF-1 is central to the regulation of production,
maintenance and function of macrophages [45]. NFKB
and  MYD88, which are responsible for inducing the
expression of many of the above mentioned chemokines
and CAM [46-50], were also up regulated suggesting their
crucial role in hepatic leukocytes migration and activa-
tion.
Metabolism and APR
A large group of metabolism genes were down regulated
in the bovine liver in response to IM LPS infusion. Of par-
ticular interest was the increased expression of PRKAB1, a
regulatory subunit of AMP-activated protein kinase
(AMPK), as recent findings show that AMPK plays a major
role in the control of hepatic metabolism [51]. Activation
of AMPK leads to inhibition of glucose production and we
did indeed observe decreased expression of the gluconeo-
genic key enzymes PCK1 and G6PC and their transcrip-
tional co-activator PGC-1α  [52]. Moreover, down
regulation of the expression of PCK1 and G6PC by STAT3
[53] whose expression levels was increased in our study,
indicates that the hepatic metabolism may also be influ-
enced by transcription factors from the signaling path-
ways in APR. Signaling gene networks were also shown to
be coordinately regulated in the liver of periparturient
cows in response to ketosis [54]. In general our results
does support the findings that the inflammatory response
affects metabolism in dairy cows [55].
Conclusion
Performing global gene expression analysis on liver tissue
from IM LPS treated cows verified that the liver plays a
major role in the APR of E. coli mastitis, and that the
bovine hepatic APR follows the same pattern as other
mammals when they are challenged with LPS. Our work
presents the first insight into the dynamic changes in gene
expression in the liver that influences the induction, kinet-
ics and clinical outcome of the APR in dairy cows.
Methods
Animals and LPS treatment
The experimental design has previously been reported
[10]. In short eight healthy, high yielding (38 kg milk per
day) Holstein-Friesian dairy cows in their first lactation (9
to 12 weeks after calving) were chosen for this study. The
udder health of the cows was evaluated based on somatic
cell count (SCC) and bacteriological examinations. All
cows had SCC < 100,000 on both front quarters and SCC
< 138,000 on both behind quarters, and were free from
mastitis pathogens. Sterile polyvinyl catheters (Micro-
Renathane) were inserted into the jugular vein of the
cows. The catheters were flushed with a sterile 0.9% NaCl
solution containing 50 IU/ml Na-heparin (Loevens
Kemiske Fabrik, Ballerup, Denmark). At time 0 the right
front quarter was infused with 200 μg  E. coli LPS
(0111:B4) (Sigma-Aldrich, Brøndby, Denmark) dissolved
in 10 ml 0.9% NaCl solution, the left front quarter serving
as control was infused with 10 ml 0.9% NaCl solution.
Production data, clinical signs as well as blood and milk
parameters associate with LPS treatment were recorded
throughout the experiment. The clinical and paraclinical
findings verified the induction of mastitis inflammation
by LPS. LPS intra-mammary infusion induced fever and a
high SCC in the milk of the treated quarter. Further,
increased concentrations of TNF-α, SAA, HP were found
simultaneously with temporary leukopenia followed by
leukocytosis and all characteristic observations in an LPS
IM infusion model. Quantitative PCR also confirmed the
high expression of cytokines TNF-α, IL-1β, IL-6 and IL-10
and the acute phase proteins SAA3 and HP in the liver fol-
lowing IM LPS infusion [10].
All procedures involving animals were approved by the
Danish Animal Experiments Inspectorate and complied
with the Danish Ministry of Justice Laws concerning ani-
mal experimentation and care of experimental animals.
Liver biopsies
Liver biopsies were taken at -22, 3, 6, 9, 12 and 48 hours
relative to LPS infusion in 4 cows, and also at -22, 9 and
48 hours in the remaining 4 cows. Sampling procedures
for liver biopsies were as previously described [56]. A con-
trol study using cows infused with 0.9% NaCl showed
that there was no effect of taking the biopsy, neither in the
clinical measurement nor in the expression of a selected
subset of genes [10]. Therefore, only 36 samples taken
from the LPS treated cows were measured for the gene
expression using microarrays.
RNA purification and microarray processing
Isolation and labeling of RNA and microarray processing
were performed as described elsewhere [57]. RNA from
liver biopsies was isolated using Trizol Reagent (Invitro-
gen, Taastrup, Denmark). Five μg RNA was labeled usingBMC Genomics 2008, 9:443 http://www.biomedcentral.com/1471-2164/9/443
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the SuperScript Choice System (Life Technologies)
according to the manufacturer's instructions, except for
using an oligo-dT primer containing a T7 RNA polymerase
promoter site. Biotin labeled cRNA was prepared using
the BioArray High Yield RNA Transcript Labeling Kit
(Enzo, Farmingdale NY, USA). 15 μg of cRNA was loaded
onto the probe array cartridge of Bovine Genome Array
(Affymetrix Clara CA, USA). The array contains 24128
probe sets which represent 15264 UniGene (annotation
from May, 2006) to measure the global transcripts.
Hybridization mixture of each sample (a specific cow at a
certain time point) was loaded to an array resulting in a
total of 36 arrays.
Annotation
Bovine Genome Array annotation is available from the
NetAffx. Genes and gene products attributes are character-
ized with the Gene Ontology (GO). However, in NetAffx
(December, 2005) only ~16% of probe sets on the array
were GO annotated. Additional annotation was obtained
from the Ensembl database, using the biomaRt package in
R [58] as the query interface. The query IDs (Ensembl gene
ID, Entrez gene ID or Affy probe set ID) were extracted
from the NetAffy annotation. Besides bovine genes, we
also retrieved the annotation based on gene sequences of
the human ortholog in Ensembl. From above resources
~48% of the probe sets on the array were able to be anno-
tated with GO.
Statistical analysis
The data was analyzed using R (version 2.4.1), a program-
ming language and development environment for statisti-
cal computing and graphics. Normalization of expression
values was performed using the GeneChip Robust Multi-
array Analysis (GCRMA) algorithm [59,60]. In this algo-
rithm, raw intensity values are background corrected
based on a model using sequence information followed
by quantile normalization [60,61]. This algorithm com-
bines the strength of stochastic-model based algorithms
and physical models and has been shown to be superior
in accuracy and precision to other normalization methods
such as MAS, RMA and PerfectMatch [62]. The microarray
data has been deposited in the Gene Expression Omnibus
database (accession GSE10695).
Differential expression of individual genes was assessed
using linear modeling and empirical Bayes methods [63]
as implemented in the R package Linear Models for Micro-
array Analysis, LIMMA [64]. The linear models allows for
general changes in gene expression between successive
time points (3 to -22, 6 to 3, 9 to 6, 12 to 9 and 48 to 12).
Each transcript targeted by the probe set was tested for the
expression change between all pairs of the successive time
points using a modified t-test, and for multiple contrasts
using a moderated F test. The residual standard deviations
are moderated across the probe sets to ensure more stable
inference for each transcript. The moderated standard
deviations are a compromise between the individual tran-
script-wise standard deviations and an overall pooled
standard deviation. Since 24128 transcripts were meas-
ured by the array and tested for the alteration simultane-
ously, the multiple-tests adjustment is introduced to
control the number of false positives. The multiple testing
was accounted for using the Bonferroni method. Tran-
scripts were deemed differentially expressed (DE) if one or
more adjusted P values for the moderated t-test was below
0.01. The adjusted moderated F statistics also showed that
all DE transcripts, except [GenBank: CK775003] (the
probe set is Bt.21216.1.S1_at), were significant.
To identify co-expression clusters, the 4610 DE transcripts
were ordered by the hierarchical clustering. Centered Pear-
son correlation method was used as the distance measure.
The optimum cluster number was determined using the
ratio of the sums of squares between and within cluster
[65] (see Figure 5).
Determine the number of clusters Figure 5
Determine the number of clusters. 4610 differentially 
expressed transcripts were hierarchically clustered using 
Centered Pearson correlation. The optimum cluster number 
(X-axis) was determined using the ratio of the sums of 
squares between and within cluster (Y-axis). We chose 8 
clusters as it classified the transcripts into relatively few clus-
ters while maintaining maximum similarity of expression pat-
tern within the same cluster.
51 0 1 5 2 0
0
.
1
6
0
.
1
8
0
.
2
0
0
.
2
2
0
.
2
4
within / between ratio VS cluster number
cluster number
r
a
t
i
o
 
o
f
 
a
v
e
r
a
g
e
 
d
i
s
t
a
n
c
e
 
w
i
t
h
i
n
 
/
 
b
e
t
w
e
e
n
 
c
l
u
s
t
e
r
sBMC Genomics 2008, 9:443 http://www.biomedcentral.com/1471-2164/9/443
Page 11 of 12
(page number not for citation purposes)
Gene set enrichment
There are 1789 UniGenes possessing Gene Ontology
(GO) among all DE transcripts in contrast to 6843 Uni-
Genes from the whole array. Within each co-expression
cluster, overrepresentation of gene sets defined by the Bio-
logical Process (BP) of GO was tested using Fisher's exact
test.
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